Management ChangeJul 10, 2026, 04:08 PM
Cadrenal Therapeutics CMO James Ferguson Resigns
AI Summary
Cadrenal Therapeutics, Inc. announced that its Chief Medical Officer, James J. Ferguson III, advised the Board of Directors of his decision to resign. His resignation is effective July 31, 2026. The company has initiated a search for his replacement and is negotiating the terms of separation with Dr. Ferguson.
Key Highlights
- Cadrenal Therapeutics' Chief Medical Officer, James J. Ferguson III, resigned.
- Dr. Ferguson's resignation is effective July 31, 2026.
- The company is actively searching for a replacement Chief Medical Officer.
- Cadrenal Therapeutics and Dr. Ferguson are negotiating separation terms.
Price Impact
More from CVKD